Oracle's Ellison Scraps Share-Sale Plan as AI Bill Comes Due

Oracle co-founder Larry Ellison terminated his Rule 10b5-1 trading plan on 12 September, halting a sale of up to 50 million shares.

Larry Ellison has reversed course on a stock disposal that would have offloaded as many as 50 million Oracle shares. The executive chair and co-founder terminated his Rule 10b5-1 trading plan on 12 September, pulling the plug on an arrangement that would have automatically sold equity in the software giant. It is a striking gesture from a founder who, by any reading, is doubling down on his own company at a moment when the market is doing anything but.

The timing is hard to ignore. Oracle had just wrapped a quarter that beat Wall Street's revenue expectations, lifted its full-year outlook, and yet still finds its shares trading at EUR 121.94 — barely above the 50-day moving average of EUR 122.27. Since the start of the year, the stock has shed 27 percent, with a further 2.9 percent decline to EUR 121.62 logged in the prior session. The signal from the top is loud; the market's response has been muted.

A Founder's Bet Against the Tape

There are two ways to read Ellison's retreat from the sale. The cynical take: with the stock this weak, a disposal simply wasn't attractive. The more generous interpretation: the patriarch still believes in the story even after months of heavy selling pressure. The two are not mutually exclusive, and the truth likely sits somewhere between them.

What is clear is that the move lands against a backdrop of genuine tension. Oracle is spending aggressively on AI cloud capacity while simultaneously tightening its belt — a combination that has left investors weighing the cost and risk side of the ledger more heavily than the operational progress.

The Numbers Behind the Noise

Reuters reported that first-quarter revenue for fiscal 2027 topped expectations, driven by demand in the AI cloud business. Perhaps more tellingly, cash burn came in lighter than feared — a detail that suggests Oracle is managing its aggressive investment pace better than initially assumed.

Against that, the company flagged roughly USD 700 million in additional restructuring costs, including job cuts. This is not a contradiction so much as the price tag of a rebuild on this scale: growth on one side, retrenchment on the other.

The forward guidance remains ambitious. Oracle raised its fiscal 2027 total revenue target to at least USD 90 billion and guided for second-quarter revenue growth of 30 to 34 percent, with cloud revenue expanding 65 to 71 percent. New customer wins reinforce the operational momentum — Quorum Health, for instance, is consolidating its corporate, financial, and clinical technology platforms onto Oracle. On the infrastructure side, the company's Project Jupiter initiative in New Mexico has put two gigawatts of new renewable energy out to tender, a signal that Oracle is planning for the long haul rather than trimming for the short term.

Analysts Split, Chart Still Weak

The professional view is not uniform. BMO Capital Markets cut its price target on 11 September from USD 220 to USD 195, while keeping an "Outperform" rating — optimistic in stance, more cautious in expectation. Argus Research, for its part, reaffirmed a buy recommendation. Such calls are best read as an indication that professional observers weight the substance behind the numbers differently than the current share price suggests, not as a blueprint.

Technically, the picture offers little comfort. Oracle trades roughly 15 percent below its 200-day moving average, a sign that the medium-term downtrend remains intact. Should the cash-flow gap widen without the projected cloud growth rates materializing, pressure on the stock is likely to persist.

What Decides the Next Move

The single factor that will settle the debate over the coming months is the recovery of operating cash flow relative to the cost of AI infrastructure. Reuters reported that analysts see a cash-flow rebound as still distant, even as the company pours money into AI capacity. That tension — between growth investment and liquidity strain — is the heart of the valuation question.

If the investment offensive translates into revenue, the market's current skepticism could unwind, and Ellison's decision to hold would look like an early vote of confidence. If the cash-flow recovery slips further into the future while infrastructure spending on projects like Jupiter keeps climbing, the fundamental headwind will outweigh any symbolic gesture from the corner office.

The next concrete test arrives with the operating cash flow figures in upcoming quarterly reports — the first real evidence of whether the raised revenue target of at least USD 90 billion comes with a stabilized liquidity position. Until then, Oracle remains a case where fundamentals and price action are pulling in different directions.